Home › Funds › Sands Capital Alternatives, LLC › TSHA
Sands Capital Alternatives, LLC position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
Sands Capital Alternatives, LLC reported holding 724,873 shares of TSHA (TAYSHA GENE THERAPIES INC) in its Q3 2026 13F filing — a position valued at US$3.5M, representing 0.52% of its reported portfolio and ranking #23 among its reported holdings. Sands Capital Alternatives, LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sands Capital Alternatives, LLC's TSHA position evolved
Sands Capital Alternatives, LLC first disclosed a stake in TSHA in Q3 2023 at 724,873 shares (US$2.3M). The position peaked in Q2 2026 at 724,873 shares, worth US$4.9M. Across 13 filings, Sands Capital Alternatives, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 724,873 shares valued at US$3.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 724.87K | $2.29M | New |
| Q4 2023 | 724.87K | $1.28M | Hold |
| Q1 2024 | 724.87K | $2.08M | Hold |
| Q2 2024 | 724.87K | $1.62M | Hold |
| Q3 2024 | 724.87K | $1.46M | Hold |
| Q4 2024 | 724.87K | $1.25M | Hold |
| Q1 2025 | 724.87K | $1.01M | Hold |
| Q2 2025 | 724.87K | $1.67M | Hold |
| Q3 2025 | 724.87K | $2.37M | Hold |
| Q4 2025 | 724.87K | $3.99M | Hold |
| Q1 2026 | 724.87K | $3.24M | Hold |
| Q2 2026 | 724.87K | $4.94M | Hold |
| Q3 2026 | 724.87K | $3.53M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TSHA and 13F data
TSHA (TAYSHA GENE THERAPIES INC) is a Health Care company. 49 other funds we track also report a position in TSHA — the largest reported positions include Avoro Capital Advisors LLC (US$162.7M), RA CAPITAL MANAGEMENT, L.P. (US$160.4M), Vestal Point Capital, LP (US$132.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TSHA
- Avoro Capital Advisors LLC 23.89M sh · $162.68M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 23.56M sh · $160.41M · Q2 2026
- Vestal Point Capital, LP 19.41M sh · $132.22M · Q2 2026
- RTW INVESTMENTS, LP 13.56M sh · $92.35M · Q2 2026
- Octagon Capital Advisors LP 9.69M sh · $66.01M · Q2 2026
- Siren, L.L.C. 9.85M sh · $47.95M · Q3 2026
- MPM BioImpact LLC 4.50M sh · $30.64M · Q2 2026
- BAKER BROS. ADVISORS LP 4.00M sh · $27.27M · Q2 2026
- GordonMD Global Investments LP 723.18K sh · $24.50M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- ADAR1 Capital Management, LLC 3.04M sh · $20.71M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 1.99M sh · $13.57M · Q2 2026
More on Sands Capital Alternatives, LLC
FAQ
How long has Sands Capital Alternatives, LLC held TSHA?
Sands Capital Alternatives, LLC has disclosed TSHA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sands Capital Alternatives, LLC's current position in TSHA?
As of Q3 2026, Sands Capital Alternatives, LLC holds 724.87K shares of TSHA (TAYSHA GENE THERAPIES INC), valued at $3.53M, representing 0.52% of its reported portfolio and ranking #23.
Has Sands Capital Alternatives, LLC been buying or selling TSHA?
In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in TSHA. The position peaked in Q2 2026 at 724.87K shares.
Which other funds hold TSHA?
Other major institutional holders of TSHA include Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.